О нас

Наш партнер

По требованию

ГЕНОМИКА ОТКРЫТА

Name: GENOMICS UNLOCKED
Address: MGI tech GmbH

Исследуйте безграничный мир геномных вебинаров.

ГЕНОМИКА ОТКРЫТА

Исследуйте безграничный мир геномных вебинаров.

ГЕНОМИКА ОТКРЫТА

Исследуйте безграничный мир геномных вебинаров.

Добро пожаловать в Genomics Unlocked

Погрузитесь вместе с нами в удивительный мир геномной науки. Почувствуйте революцию приложений геномики через серию вебинаров, проводимых ведущими учеными.

Наши сотрудничества

Последний вебинар

View all

Speakers

Koeraad EYCKEN, Chief product officer, OncoDNA

Filips Oleskovs, Business Development Manager, MGI

Alejandra María Pérez Sastre, PhD., Services Direction Manager, Sistemas Genómicos

Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients

22 апр. 2025 г.

Speakers

Koeraad EYCKEN, Chief product officer, OncoDNA

Filips Oleskovs, Business Development Manager, MGI

Alejandra María Pérez Sastre, PhD., Services Direction Manager, Sistemas Genómicos

Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients

22 апр. 2025 г.

Speakers

Koeraad EYCKEN, Chief product officer, OncoDNA

Filips Oleskovs, Business Development Manager, MGI

Alejandra María Pérez Sastre, PhD., Services Direction Manager, Sistemas Genómicos

Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients

22 апр. 2025 г.

Speakers

Koeraad EYCKEN, Chief product officer, OncoDNA

Filips Oleskovs, Business Development Manager, MGI

Alejandra María Pérez Sastre, PhD., Services Direction Manager, Sistemas Genómicos

Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients

22 апр. 2025 г.

22 апр. 2025 г.

Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients

Join our webinar to lear how OncoDNA and MGI partnership isshaping the future of precision medicine in oncology, to provide more affordable access to NGS technology, and better insghts.

22 апр. 2025 г.

Unlocking precision Oncology: How OncoDNA and MGI provide accessible CPG for cancer patients

Join our webinar to lear how OncoDNA and MGI partnership isshaping the future of precision medicine in oncology, to provide more affordable access to NGS technology, and better insghts.

Making the implementation of monogenic hereditary diseases diagnosis easy Speaker details but you dont need to include this in the description Dr. Paula Sancho Salmerón, PhD, Product Manager GeneSystems @Sistemas Genómicos

17 июн. 2024 г.

14 min

Making The Implementation of Monogenic Hereditary Diseases Diagnosis Easy

Discover how to simplify the diagnosis of monogenic hereditary diseases with advanced solutions. Learn practical steps and innovative methods to streamline genetic testing, making implementation easier and more efficient for healthcare providers.

17 июн. 2024 г.

14 min

Making The Implementation of Monogenic Hereditary Diseases Diagnosis Easy

Comprehensive Molecular Tumour Analysis (CMTA) integrates RNA-seq and the Tumour Microenvironment (TME) for targeted therapy Speaker, Dr. Marie-laure Yaspo

17 июн. 2024 г.

28 min

Integrating RNA-seq and Tumor Microenvironment (TME)

Discover how (CMTA) revolutionizes cancer treatment. Learn how integrating RNA-seq and Tumor Microenvironment (TME) data with MGI DNBSEQ technology offers precise, targeted therapies, enhancing personalized care and patient outcomes.

17 июн. 2024 г.

28 min